Episode 274 The Blood Test That Tells You Which Chemo Will Actually Work (Before You Ever Take It)

What if you could test your cancer cells BEFORE choosing a treatment and actually watch which drugs kill them?

That’s not science fiction. That’s what we did for Kamren — a 38-year-old man in my own family who was diagnosed with a rare, complex cancer that conventional medicine struggled to classify, let alone treat.

In this episode, I’m pulling back the curtain on three precision tests that most oncologists have never ordered and explaining exactly what they revealed, what they changed, and why they matter for every cancer patient, not just his.

We’re talking about:

🔬 Northstar Response: the liquid biopsy that tracks your tumor’s activity in real time through a single blood draw

🧬 Northstar Select: the genomic test that mapped the exact mutations driving his cancer and matched them to targeted therapies and clinical trials

🧪 DATAR Chemo-Scale: the live cell test that grew his actual tumor cells in a lab and tested 70+ drugs against them to find out which ones truly work on his cancer

This episode isn’t about hope. It’s about data. It’s about refusing to let a protocol designed for the average patient be applied to someone who is anything but average.

If you or someone you love is navigating a cancer diagnosis, this episode could change the questions you ask and the care you receive.

Donate – Any amount makes a difference
https://www.freefunder.com/campaign/rare-male-breast-cancer

Connect with us:
Website: https://www.letstalkwellness.com
Instagram: https://www.instagram.com/letstalk_wellnessnow/
Facebook: https://www.facebook.com/LetsTalkWellnessNowPodcast
LinkedIn: https://www.linkedin.com/company/lets-talk-wellness-now/

Subscribe to Let’s Talk Wellness Now so you never miss an episode, and if this one opened your eyes, share it with someone who needs to hear it.

    Comments are closed

    Discover more from Let's Talk Wellness Now

    Subscribe now to keep reading and get access to the full archive.

    Continue reading